ProShares Ultra Nasdaq Biotechnology (BIB)Trading--Leveraged Equity | Exchange Traded Fund | NasdaqGM
105.20 USD
-3.20
(-2.952%) ⇩
(Oct. 13, 2026, 9:53 a.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 2:09 a.m. EDT
The 2x leveraged biotech ETF is currently trapped in a structural downtrend, having lost nearly half its value since its 2020 peak despite a recent technical recovery. While the price has bounced off the 200-day moving average, the underlying momentum remains fragile, evidenced by the heavy speculative positioning in out-of-the-money puts which signals a fear of further volatility. The recent price action shows a struggle to sustain gains above the 50-day average, suggesting the rally is more of a relief bounce than a trend reversal. For investors, the high leverage acts as a double-edged sword here: it amplifies the pain of the sector's broader weakness, making a simple 'buy and hold' strategy perilous without a confirmed break above key resistance levels. The statistical forecast offers only a weak lean upward, confirming that the market is undecided on whether this is a bottom or a continuation of the decline. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.048976 |
| MSTL | 0.098472 |
| AutoARIMA | 0.099508 |
| AutoETS | 0.099509 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 43% |
| H-stat | 1.59 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.136 |
| Excess Kurtosis | -0.59 |
| Attribute | Value |
|---|---|
| Trailing P/E | 29.79 |
As of Oct. 10, 2026, 2:09 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put volume relative to calls, particularly in the November and February expirations where OTM put open interest dominates. This suggests a fear of a significant downside gap or a 'crash' scenario rather than a steady decline. Conversely, call activity is concentrated near the money, indicating traders are hedging existing long positions or betting on a modest bounce to the 110-115 range, but lacking the aggressive leverage seen in the put side.
| Last Yield | 1yr Yield | 3yr Avg | 5yr Avg |
|---|---|---|---|
| 0.07% | 0.24% | 0.93% | 0.56% |
| Date | Dividend | Yield % |
|---|---|---|
| 2026-09-23 | 0.083 | 0.074081 |
| 2026-03-25 | 0.007 | 0.008891 |
| 2025-12-24 | 0.135 | 0.160983 |
| 2025-09-24 | 0.181 | 0.314618 |
| 2025-06-25 | 0.171 | 0.372225 |
| 2025-03-26 | 0.131 | 0.258740 |
| 2024-12-23 | 0.396 | 0.763006 |
| 2024-09-25 | 0.153 | 0.247013 |
| 2024-06-26 | 0.265 | 0.445303 |
| 2024-03-20 | 0.040 | 0.070547 |
| 2023-12-20 | 0.038 | 0.074437 |
| 2022-12-22 | 0.020 | 0.033256 |
| 2010-09-21 | 0.011 | 0.170874 |
| Attribute | Value |
|---|---|
| All Time High | 126.4 |
| All Time Low | 4.24125 |
| Ask | 105.06 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 7,160 |
| Average Daily Volume3 Month | 9,471 |
| Average Volume | 9,471 |
| Average Volume10Days | 7,160 |
| Beta3 Year | 1.12 |
| Bid | 98.19 |
| Bid Size | 1 |
| Category | Trading--Leveraged Equity |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 105.2 |
| Day Low | 105.0541 |
| Display Name | Ultra Nasdaq Biotechnology |
| Dividend Date | 1,285,632,000 |
| Dividend Yield | 0.19 |
| Eps Trailing Twelve Months | 3.5310361 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 112.7448 |
| Fifty Day Average Change | -7.5448 |
| Fifty Day Average Change Percent | -0.066919275 |
| Fifty Two Week Change Percent | 68.249306 |
| Fifty Two Week High | 126.4 |
| Fifty Two Week High Change | -21.200005 |
| Fifty Two Week High Change Percent | -0.16772155 |
| Fifty Two Week Low | 62.72 |
| Fifty Two Week Low Change | 42.479996 |
| Fifty Two Week Low Change Percent | 0.67729586 |
| Fifty Two Week Range | 62.72 - 126.4 |
| First Trade Date Milliseconds | 1,270,819,800,000 |
| Five Year Average Return | 0.0549029 |
| Full Exchange Name | NasdaqGM |
| Fullday Change | -3.2005005 |
| Fullday Change Percent | -2.9524777 |
| Fullday Price | 105.2 |
| Fund Family | ProShares |
| Fund Inception Date | 1,270,512,000 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified. |
| Long Name | ProShares Ultra Nasdaq Biotechnology |
| Market | us_market |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_100661718 |
| Nav Price | 110.9566 |
| Net Assets | 96,798,472.0 |
| Net Expense Ratio | 0.95 |
| Open | 105.0541 |
| Previous Close | 108.4005 |
| Price Hint | 2 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | -3.2005005 |
| Regular Market Change Percent | -2.9524777 |
| Regular Market Day High | 105.2 |
| Regular Market Day Low | 105.0541 |
| Regular Market Day Range | 105.0541 - 105.2 |
| Regular Market Open | 105.0541 |
| Regular Market Previous Close | 108.4005 |
| Regular Market Price | 105.2 |
| Regular Market Time | 1,791,899,608 |
| Regular Market Volume | 717 |
| Short Name | ProShares Ultra Nasdaq Biotechn |
| Source Interval | 15 |
| Symbol | BIB |
| Three Year Average Return | 0.3383935 |
| Total Assets | 96,798,472 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing P E | 29.792953 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 14.41096 |
| Trailing Three Month Returns | 14.41096 |
| Triggerable | 1 |
| Two Hundred Day Average | 92.7345 |
| Two Hundred Day Average Change | 12.4655 |
| Two Hundred Day Average Change Percent | 0.1344214 |
| Type Disp | ETF |
| Volume | 717 |
| Yield | 0.0019 |
| Ytd Return | 44.59152 |